Also trades as: HTGM (NASDAQ) · $vol 0M
HTGMQ OTC
HTG Molecular Diagnostics, Inc.
1W: +0.0%
1M: +9900.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.6%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$6M
-28.5% ▼
5Y CAGR: -15.5%
Gross Profit
$2M
-62.7% ▼
5Y CAGR: -28.8%
Operating Income
-$21M
-16.9% ▼
Net Income
-$22M
-26.0% ▼
EPS (Diluted)
$-24.28
+18.1% ▲
EBITDA
-$20M
-31.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $22M | $19M | $9M | $9M | $6M |
| YoY Growth | +45.7% | -10.7% | -55.5% | +4.2% | -28.5% |
| Cost of Revenue | $5M | $9M | $4M | $4M | $5M |
| Gross Profit | $16M | $10M | $5M | $5M | $2M |
| Gross Margin | 76.3% | 53.6% | 53.3% | 54.0% | 28.2% |
| R&D Expenses | $13M | $11M | $6M | $6M | $7M |
| SG&A Expenses | $20M | $19M | $18M | $17M | $16M |
| Operating Expenses | $33M | $29M | $25M | $23M | $23M |
| Operating Income | -$16M | -$19M | -$20M | -$18M | -$21M |
| Operating Margin | -75.1% | -98.7% | -229.1% | -200.1% | -327.2% |
| Interest Expense | $902K | $958K | $1M | $1M | $857K |
| Income Before Tax | -$16M | -$19M | -$21M | -$17M | -$22M |
| Tax Expense | $4K | $3K | $14K | $22K | $11K |
| Net Income | -$16M | -$19M | -$21M | -$17M | -$22M |
| Net Margin | -76.5% | -100.5% | -244.1% | -192.5% | -339.2% |
| EPS (Diluted) | $-107.61 | $-91.17 | $-54.12 | $-29.66 | $-24.28 |
| EBITDA | -$14M | -$17M | -$18M | -$15M | -$20M |
| Shares Outstanding | 152908 | 211664 | 385659 | 578010 | 889284 |